,title,source,link,date
8,Salmeterol Market Breathing Easier with 2023-2030 Forecasts ...,Digital Journal,news.google.com/articles/CBMinQFodHRwczovL3d3dy5kaWdpdGFsam91cm5hbC5jb20vcHIvbmV3cy9jZG4tbmV3c3dpcmUvc2FsbWV0ZXJvbC1tYXJrZXQtYnJlYXRoaW5nLWVhc2llci13aXRoLTIwMjMtMjAzMC1mb3JlY2FzdHMtbHVwaW4tbGltaXRlZC1teWxhbi1nbGF4b3NtaXRoa2xpbmUtbWlkYXNjYXJl0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-10-09
9,Pioneering the Frontiers of Pharma Innovation: A Recap of 5th Elets ...,Elets,news.google.com/articles/CBMiiwFodHRwczovL2VoZWFsdGguZWxldHNvbmxpbmUuY29tLzIwMjMvMTAvcGlvbmVlcmluZy10aGUtZnJvbnRpZXJzLW9mLXBoYXJtYS1pbm5vdmF0aW9uLWEtcmVjYXAtb2YtNXRoLWVsZXRzLXBoYXJtYS1sZWFkZXJzaGlwLXN1bW1pdC1hd2FyZHMv0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-10-09
19,"Aspergillosis Drugs Market 2023 by Keyplayers and Vendors: Merck, Pfizer Deutschland GmbH, GSK, Janssen Pha...",SeeDance News,news.google.com/articles/CBMimwFodHRwczovL3d3dy5zZWVkYW5jZS5jb20vYXNwZXJnaWxsb3Npcy1kcnVncy1tYXJrZXQtMjAyMy1ieS1rZXlwbGF5ZXJzLWFuZC12ZW5kb3JzLW1lcmNrLXBmaXplci1kZXV0c2NobGFuZC1nbWJoLWdzay1qYW5zc2VuLXBoYXJtYWNldXRpY2EtYXN0ZWxsYXMtYmFzaWxlL9IBnwFodHRwczovL3d3dy5zZWVkYW5jZS5jb20vYXNwZXJnaWxsb3Npcy1kcnVncy1tYXJrZXQtMjAyMy1ieS1rZXlwbGF5ZXJzLWFuZC12ZW5kb3JzLW1lcmNrLXBmaXplci1kZXV0c2NobGFuZC1nbWJoLWdzay1qYW5zc2VuLXBoYXJtYWNldXRpY2EtYXN0ZWxsYXMtYmFzaWxlL2FtcC8?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-10-09
23,"Treat Oncology Drug Market Latest Advancements and Business Opportunities 2023 to 2029 â€“ Novartis AG,...",SeeDance News,news.google.com/articles/CBMirQFodHRwczovL3d3dy5zZWVkYW5jZS5jb20vdHJlYXQtb25jb2xvZ3ktZHJ1Zy1tYXJrZXQtbGF0ZXN0LWFkdmFuY2VtZW50cy1hbmQtYnVzaW5lc3Mtb3Bwb3J0dW5pdGllcy0yMDIzLXRvLTIwMjktbm92YXJ0aXMtYWctY2VsZ2VuZS1jb3Jwb3JhdGlvbi1tZXJjay1jb21wYW55LWluYy1wZml6ZXItaW5jL9IBsQFodHRwczovL3d3dy5zZWVkYW5jZS5jb20vdHJlYXQtb25jb2xvZ3ktZHJ1Zy1tYXJrZXQtbGF0ZXN0LWFkdmFuY2VtZW50cy1hbmQtYnVzaW5lc3Mtb3Bwb3J0dW5pdGllcy0yMDIzLXRvLTIwMjktbm92YXJ0aXMtYWctY2VsZ2VuZS1jb3Jwb3JhdGlvbi1tZXJjay1jb21wYW55LWluYy1wZml6ZXItaW5jL2FtcC8?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-10-06
3,An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 42% Undervalued,Simply Wall St,news.google.com/articles/CBMinAFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL2luL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25zZS1uYXRjb3BoYXJtL25hdGNvLXBoYXJtYS1zaGFyZXMvbmV3cy9hbi1pbnRyaW5zaWMtY2FsY3VsYXRpb24tZm9yLW5hdGNvLXBoYXJtYS1saW1pdGVkLW5zZW5hdGNvcGjSAaABaHR0cHM6Ly9zaW1wbHl3YWxsLnN0L3N0b2Nrcy9pbi9waGFybWFjZXV0aWNhbHMtYmlvdGVjaC9uc2UtbmF0Y29waGFybS9uYXRjby1waGFybWEtc2hhcmVzL25ld3MvYW4taW50cmluc2ljLWNhbGN1bGF0aW9uLWZvci1uYXRjby1waGFybWEtbGltaXRlZC1uc2VuYXRjb3BoL2FtcA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-30
13,Patent Licensing In India - Patent - India,Mondaq News Alerts,news.google.com/articles/CBMiRWh0dHBzOi8vd3d3Lm1vbmRhcS5jb20vaW5kaWEvcGF0ZW50LzEzNzA4MjIvcGF0ZW50LWxpY2Vuc2luZy1pbi1pbmRpYdIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-28
